Demographic, Socioeconomic, and Clinical Factors Associated with Severe Vision Loss in Patients with Neovascular Glaucoma

References

• Havens SJ, Gulati V. Neovascular Glaucoma. Dev Ophthalmol. 2016;55:196–204. doi:10.1159/000431196
   PubMedGoogle Scholar
• Shchomak Z, Cordeiro Sousa D, Leal I, Abegão Pinto L. Surgical treatment of neovascular glaucoma: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2019;257(6):1079–1089. doi:10.1007/s00417-019-04256-8
   PubMed Web of Science ®Google Scholar
• Lin P, Zhao Q, He J, Fan W, He W, Lai M. Comparisons of the short-term effectiveness and safety of surgical treatment for neovascular glaucoma: a systematic review and network meta-analysis. BMJ Open. 2022;12(5):e051794. doi:10.1136/bmjopen-2021-051794
   PubMed Web of Science ®Google Scholar
• Arcieri ES, Paula JS, Jorge R, et al. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up. Acta Ophthalmol (Copenh). 2015;93(1):e1–6. doi:10.1111/aos.12493
   Web of Science ®Google Scholar
• Tokumo K, Komatsu K, Yuasa Y, et al. Treatment outcomes in the neovascular glaucoma tube versus trabeculectomy study. Graefes Arch Clin Exp Ophthalmol. 2021;259(10):3067–3076. doi:10.1007/s00417-021-05257-2
   PubMed Web of Science ®Google Scholar
• Wogu B, Shalaby WS, Ganjei AY, Shukla AG. Outcomes of Baerveldt glaucoma implant and transscleral cyclophotocoagulation in neovascular glaucoma. Clin Experiment Ophthalmol. 2022;50(5):563–565. doi:10.1111/ceo.14080
   PubMed Web of Science ®Google Scholar
• Shazly TA, Latina MA. Neovascular Glaucoma: etiology, Diagnosis and Prognosis. Semin Ophthalmol. 2009;24(2):113–121. doi:10.1080/08820530902800801
   PubMed Web of Science ®Google Scholar
• Hayreh SS. NEOVASCULAR GLAUCOMA. Prog Retin Eye Res. 2007;26(5):470–485. doi:10.1016/j.preteyeres.2007.06.001
   PubMed Web of Science ®Google Scholar
• Călugăru D, Călugăru M. Etiology, pathogenesis, and diagnosis of neovascular glaucoma. Int J Ophthalmol. 2022;15(6):1005–1010. doi:10.18240/ijo.2022.06.20
   PubMed Web of Science ®Google Scholar
• Shalaby WS, Myers JS, Razeghinejad R, et al. Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma. Ophthalmol Glaucoma. 2021;4(2):182–192. doi:10.1016/j.ogla.2020.09.010
   PubMedGoogle Scholar
• Shalaby WS, Ganjei AY, Wogu B, et al. Outcomes of Ahmed glaucoma valve and transscleral cyclophotocoagulation in neovascular glaucoma. Indian J Ophthalmol. 2022;70(4):1253–1259. doi:10.4103/ijo.IJO_2107_21
   PubMed Web of Science ®Google Scholar
• Medert CM, Sun CQ, Vanner E, Parrish RK, Wellik SR. The influence of etiology on surgical outcomes in neovascular glaucoma. BMC Ophthalmol. 2021;21(1):440. doi:10.1186/s12886-021-02212-x
   PubMed Web of Science ®Google Scholar
• Takihara Y, Inatani M, Fukushima M, Iwao K, Iwao M, Tanihara H. Trabeculectomy with Mitomycin C for Neovascular Glaucoma: prognostic Factors for Surgical Failure. Am J Ophthalmol. 2009;147(5):912–918.e1. doi:10.1016/j.ajo.2008.11.015
   PubMed Web of Science ®Google Scholar
• Hernandez-Oteyza A, Lazcano-Gomez G, Jimenez-Roman J, Hernandez-Garciadiego C. Surgical Outcome of Ahmed Valve Implantation in Mexican Patients with Neovascular Glaucoma. J Curr Glaucoma Pract. 2014;8(3):86–90. doi:10.5005/jp-journals-10008-1168
   PubMedGoogle Scholar
• Iwasaki K, Kojima S, Wajima R, et al. Comparing Surgical Outcomes in Neovascular Glaucoma between Tube and Trabeculectomy: a Multicenter Study. Ophthalmol Glaucoma. 2022;5(6):672–680. doi:10.1016/j.ogla.2022.05.003
   PubMedGoogle Scholar
• Senthil S, Chary R, Ali MH, et al. Trabeculectomy for neovascular glaucoma in proliferative diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome: surgical outcomes and prognostic factors for failure. Indian J Ophthalmol. 2021;69(11):3341–3348. doi:10.4103/ijo.IJO_1516_21
   PubMed Web of Science ®Google Scholar
• Shalaby WS, Arbabi A, Myers JS, et al. Sociodemographic and Economic Factors in Outcomes of Tube Shunts for Neovascular Glaucoma. J Curr Glaucoma Pract. 2021;15(2):70–77. doi:10.5005/jp-journals-10078-1303
   PubMedGoogle Scholar
• Lazcano-Gomez G, Soohoo R, Lynch J, et al. Neovascular Glaucoma: a Retrospective Review from a Tertiary Eye Care Center in Mexico. J Curr Glaucoma Pract. 2017;11(2):48–51. doi:10.5005/jp-journals-10028-1222
   PubMedGoogle Scholar
• Schultz WM, Kelli HM, Lisko JC, et al. Socioeconomic Status and Cardiovascular Outcomes. Circulation. 2018;137(20):2166–2178. doi:10.1161/CIRCULATIONAHA.117.029652
   PubMed Web of Science ®Google Scholar
• Scott A, Chambers D, Goyder E, O’Cathain A. Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: a systematic review. PLoS One. 2017;12(5):e0177210. doi:10.1371/journal.pone.0177210
   PubMed Web of Science ®Google Scholar
• Coughlin SS. Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat. 2019;177(3):537–548. doi:10.1007/s10549-019-05340-7
   PubMed Web of Science ®Google Scholar
• Hovanec J, Siemiatycki J, Conway DI, et al. Lung cancer and socioeconomic status in a pooled analysis of case-control studies. PLoS One. 2018;13(2):e0192999. doi:10.1371/journal.pone.0192999
   PubMed Web of Science ®Google Scholar
• Gershon AS, Dolmage TE, Stephenson A, Jackson B. Chronic Obstructive Pulmonary Disease and SocioEconomic Status: a Systematic Review. COPD J Chronic Obstr Pulm Dis. 2012;9(3):216–226. doi:10.3109/15412555.2011.648030
   Web of Science ®Google Scholar
• Marshall IJ, Wang Y, Crichton S, McKevitt C, Rudd AG, Wolfe CDA. The effects of socioeconomic status on stroke risk and outcomes. Lancet Neurol. 2015;14(12):1206–1218. doi:10.1016/S1474-4422(15)00200-8
   PubMed Web of Science ®Google Scholar
• Pathirana TI, Jackson CA. Socioeconomic status and multimorbidity: a systematic review and meta-analysis. Aust N Z J Public Health. 2018;42(2):186–194. doi:10.1111/1753-6405.12762
   PubMed Web of Science ®Google Scholar
• Neighborhood Atlas - Mapping. Available from: https://www.neighborhoodatlas.medicine.wisc.edu/mapping. Accessed June 12, 2023.
   Google Scholar
• U.S. Census Bureau QuickFacts: United States. Available from: https://www.census.gov/quickfacts/fact/map/US/INC110221. Accessed June 12, 2023.
   Google Scholar
• Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK. Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study: the Impact of Treatment and other Baseline Factors. Ophthalmology. 2009;116(2):200–207. doi:10.1016/j.ophtha.2008.08.051
   PubMed Web of Science ®Google Scholar
• Aptel F, Bron AM, Lachkar Y, Schweitzer C. Change in Visual Field Progression Following Treatment Escalation in Primary Open-angle Glaucoma. J Glaucoma. 2017;26(10):875–880. doi:10.1097/IJG.0000000000000748
   PubMed Web of Science ®Google Scholar
• Husain KA, Alaali H, Alderazi H. Early Surgical Intervention for Neovascular Glaucoma in a Patient with Diabetes. Cureus. 2016;13(6):e15420. doi:10.7759/cureus.15420
   Google Scholar
• Diniz-Filho A, Abe RY, Zangwill LM, et al. Association between Intraocular Pressure and Rates of Retinal Nerve Fiber Layer Loss Measured by Optical Coherence Tomography. Ophthalmology. 2016;123(10):2058–2065. doi:10.1016/j.ophtha.2016.07.006
   PubMed Web of Science ®Google Scholar
• Freeman JD, Kadiyala S, Bell JF, Martin DP. The causal effect of health insurance on utilization and outcomes in adults: a systematic review of US studies. Med Care. 2008;46(10):1023–1032. doi:10.1097/MLR.0b013e318185c913
   PubMed Web of Science ®Google Scholar
• Lee SH, Brown SL, Bennett AA. The relationship between insurance and health outcomes of diabetes mellitus patients in Maryland: a retrospective archival record study. BMC Health Serv Res. 2021;21(1):495. doi:10.1186/s12913-021-06534-w
   PubMed Web of Science ®Google Scholar
• McWilliams JM. Health consequences of uninsurance among adults in the United States: recent evidence and implications. Milbank Q. 2009;87(2):443–494. doi:10.1111/j.1468-0009.2009.00564.x
   PubMed Web of Science ®Google Scholar
• Horne G, Gautam A, Tumin D. Short- and Long-Term Health Consequences of Gaps in Health Insurance Coverage among Young Adults. Popul Health Manag. 2022;25(3):399–406. doi:10.1089/pop.2021.0211
   PubMed Web of Science ®Google Scholar
• Medford‐Davis LN, Fonarow GC, Bhatt DL, et al. Impact of Insurance Status on Outcomes and Use of Rehabilitation Services in Acute Ischemic Stroke: findings From Get With The Guidelines‐Stroke. J Am Heart Assoc. 2012;5(11):e004282. doi:10.1161/JAHA.116.004282
   Google Scholar
• Song L, Wang Y, Chen B, Yang T, Zhang W, Wang Y. The Association between Health Insurance and All-Cause, Cardiovascular Disease, Cancer and Cause-Specific Mortality: a Prospective Cohort Study. Int J Environ Res Public Health. 2020;17(5):1525. doi:10.3390/ijerph17051525
   PubMed Web of Science ®Google Scholar
• Crotty K, Marialanna Lee MSC, Treiman K, et al. Health Insurance, Blood Cancer Care, and Outcomes: a Literature Review. Int J Med. 2021;27:SP241–SP244.
   Google Scholar
• Buchmueller TC, Grumbach K, Kronick R, Kahn JG. The effect of health insurance on medical care utilization and implications for insurance expansion: a review of the literature. Med Care Res Rev MCRR. 2005;62(1):3–30. doi:10.1177/1077558704271718
   PubMed Web of Science ®Google Scholar
• Stone ML, LaPar DJ, Mulloy DP, et al. Primary payer status is significantly associated with postoperative mortality, morbidity, and hospital resource utilization in pediatric surgical patients within the United States. J Pediatr Surg. 2013;48(1):81–87. doi:10.1016/j.jpedsurg.2012.10.021
   PubMed Web of Science ®Google Scholar
• LaPar DJ, Stukenborg GJ, Guyer RA, et al. Primary payer status is associated with mortality and resource utilization for coronary artery bypass grafting. Circulation. 2012;126(11 Suppl 1):S132–139. doi:10.1161/CIRCULATIONAHA.111.083782
   PubMed Web of Science ®Google Scholar
• LaPar DJ, Bhamidipati CM, Mery CM, et al. Primary Payer Status Affects Mortality for Major Surgical Operations. Ann Surg. 2010;252(3):544–551. doi:10.1097/SLA.0b013e3181e8fd75
   PubMed Web of Science ®Google Scholar
• Hwang J, Rudnisky C, Bowen S, Johnson JA. Socioeconomic factors associated with visual impairment and ophthalmic care utilization in patients with type II diabetes. Can J Ophthalmol J Can Ophtalmol. 2015;50(2):119–126. doi:10.1016/j.jcjo.2014.11.014
   PubMed Web of Science ®Google Scholar
• Lee YH, Chen AX, Varadaraj V, et al. Comparison of Access to Eye Care Appointments Between Patients With Medicaid and Those With Private Health Care Insurance. JAMA Ophthalmol. 2018;136(6):622–629. doi:10.1001/jamaophthalmol.2018.0813
   PubMed Web of Science ®Google Scholar
• Obeid A, Gao X, Ali FS, et al. Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti-Vascular Endothelial Growth Factor Injections. JAMA Ophthalmol. 2018;136(11):1251–1259. doi:10.1001/jamaophthalmol.2018.3578
   PubMed Web of Science ®Google Scholar
• Acuff K, Delavar A, Radha Saseendrakumar B, Wu JH, Weinreb RN, Baxter SL. Associations between Socioeconomic Factors and Visit Adherence among Patients with Glaucoma in the All of Us Research Program. Ophthalmol Glaucoma. 2023. doi:10.1016/j.ogla.2023.01.008
   PubMedGoogle Scholar
• Funk IT, Strelow BA, Klifto MR, et al. The Relationship of Travel Distance to Postoperative Follow-up Care on Glaucoma Surgery Outcomes. J Glaucoma. 2020;29(11):1056–1064. doi:10.1097/IJG.0000000000001609
   PubMed Web of Science ®Google Scholar
• Green M, Tien T, Ness S. Predictors of Lost to Follow-Up in Patients Being Treated for Proliferative Diabetic Retinopathy. Am J Ophthalmol. 2020;216:18–27. doi:10.1016/j.ajo.2020.03.023
   PubMed Web of Science ®Google Scholar
• Senthil S, Dada T, Das T, et al. Neovascular glaucoma - A review. Indian J Ophthalmol. 2021;69(3):525–534. doi:10.4103/ijo.IJO_1591_20
   PubMed Web of Science ®Google Scholar
• Karmouta R, Altendahl M, Romero T, et al. Association Between Social Determinants of Health and Retinopathy of Prematurity Outcomes. JAMA Ophthalmol. 2022;140(5):496–502. doi:10.1001/jamaophthalmol.2022.0667
   PubMed Web of Science ®Google Scholar
• Xu D, Uhr J, Patel SN, et al. Sociodemographic Factors Influencing Rhegmatogenous Retinal Detachment Presentation and Outcome. Ophthalmol Retina. 2021;5(4):337–341. doi:10.1016/j.oret.2020.08.001
   PubMedGoogle Scholar
• Cao J, Patel S, Wong C, et al. Demographic and Socioeconomic Factors in Prospective Retina-Focused Clinical Trial Screening and Enrollment. J Pers Med. 2023;13:880. doi:10.3390/jpm13060880
   PubMed Web of Science ®Google Scholar